CSI Market
Sign In | Register

Endologix Inc (ELGX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access ELGX quarterly Cash Flow →
Observing cash flow movements over recent quarters helps explain how Endologix Inc adapts cash usage as operating conditions change.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2019)
12 Months 		(Dec 31 2018) (Dec 31 2017) (Dec 31 2016) (Dec 31 2015)
Operating Activities
Income-64.76
Depreciation & amortization6.89
Amortization of Other Assets14.26
Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-1.70
Provision For Loan Losses Expensed0.53
Increase (Decrease) in Inventories3.62
Research and Development in Process0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation10.85
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction19.40
Income Tax Expense Benefit Non Cash Adjustment-
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability-
Changein Contingent Consideration Relatedto Acquisition-
Operating Lease Payments3.40
Noncash Or Part Noncash Acquisition Other Assets Acquired0.10
Noncash Lease Expense0.26
Income taxes-4.95
Losses/ -gains on Investments net0.00
Accounts Receivable1.44
Increase (Decrease) in Accounts Payable3.11
Increase (Decrease) in Accrued Liabilities-1.95
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets1.12
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-21.22
Discontinued operations0.00
Net Cash flow from Operating Activities-29.57
Investing Activities
Capital Expenditures-0.46
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
License Costs-
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.46
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-3.98
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock52.33
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-24.94
Proceeds From Issuance Of Common Stock Net Of Expenses-
Increasein Restricted Cash-
Decreasein Restricted Cash-
Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt-
Treasury Stock Value Acquired Cost Method-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents24.73
Restricted Cash-
Proceeds from At The Market Shares-
Proceeds from Sale of Stock Employee Stockplan-
Proceeds from Common Stock Offering and Prepaid Warrants Net of Expenses Paid-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities48.15
Effect of exchange rate on cash flow-0.09
Discontinued operations0.00
Free Cash Flow-30.03
Total Cash Flow18.03
4 historic quarters locked

Sign in to unlock the full Endologix Inc cash flow history.

Sign In Create Free Account

About ELGX Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License